Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells
Authors:
- Parvathy VenugopalPVParvathy Venugopal
- Swathi SundarrajSSSwathi Sundarraj
- Zubaidah ZakariaZZZubaidah Zakaria
- Anish Sen MajumdarAMAnish Sen Majumdar
- Malancha TaMTMalancha Ta
- 1 January 2012
- journal article
- research article
- Published by Elsevier in Cytotherapy
- Vol. 14 (1) , 26-33
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applicationsStem Cell Research, 2010
- Nonredundant role of CCRL2 in lung dendritic cell traffickingBlood, 2010
- Mechanisms involved in the therapeutic properties of mesenchymal stem cellsCytokine & Growth Factor Reviews, 2009
- CCR3 is a target for age-related macular degeneration diagnosis and therapyNature, 2009
- Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cellsJournal of Tissue Engineering and Regenerative Medicine, 2009
- The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosisJournal of Neuroinflammation, 2009
- CXC chemokines located in the 4q21 region are up-regulated in breast cancerEndocrine-Related Cancer, 2007
- Concise Review: Human Umbilical Cord Stroma with Regard to the Source of Fetus-Derived Stem CellsStem Cells, 2007
- Human Umbilical Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's DiseaseStem Cells, 2005
- Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial diseaseGene Therapy, 2001